FR2327771A2 - Nouveaux derives des methoxy-2 benzamides substitues, leurs sels, leur preparation et les medicaments qui en renferment - Google Patents

Nouveaux derives des methoxy-2 benzamides substitues, leurs sels, leur preparation et les medicaments qui en renferment

Info

Publication number
FR2327771A2
FR2327771A2 FR7531334A FR7531334A FR2327771A2 FR 2327771 A2 FR2327771 A2 FR 2327771A2 FR 7531334 A FR7531334 A FR 7531334A FR 7531334 A FR7531334 A FR 7531334A FR 2327771 A2 FR2327771 A2 FR 2327771A2
Authority
FR
France
Prior art keywords
alkyl
useful
psychosomatic
substd
heterocyclylmethy
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR7531334A
Other languages
English (en)
Other versions
FR2327771B2 (fr
Inventor
Jean-Pierre Kaplan
Bernard Michel Raizon
Daniel Charles Leon Obitz
Philippe Michel Jacque Manoury
Henry Najer
Maurice Jalfre
Don Pierre Rene Luc Giudicelli
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Synthelabo SA
Original Assignee
Synthelabo SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Synthelabo SA filed Critical Synthelabo SA
Priority to FR7531334A priority Critical patent/FR2327771A2/fr
Priority to CA241,723A priority patent/CA1039731A/fr
Priority to SE7514143A priority patent/SE412908B/xx
Priority to DE2556457A priority patent/DE2556457C3/de
Priority to IE2731/75A priority patent/IE42210B1/en
Priority to NO754284A priority patent/NO143625C/no
Priority to LU74026A priority patent/LU74026A1/xx
Priority to IL48678A priority patent/IL48678A/xx
Priority to NLAANVRAGE7514620,A priority patent/NL168219C/xx
Priority to MX001641U priority patent/MX3180E/es
Priority to DK574075A priority patent/DK574075A/da
Priority to GB51635/75A priority patent/GB1508880A/en
Priority to ES75443563A priority patent/ES443563A1/es
Priority to GR49632A priority patent/GR59205B/el
Priority to AU87646/75A priority patent/AU497616B2/en
Priority to AT959075A priority patent/AT353782B/de
Priority to HU75SI1501A priority patent/HU173391B/hu
Priority to FI753586A priority patent/FI753586A/fi
Priority to CH1641375A priority patent/CH612668A5/xx
Priority to JP2551576A priority patent/JPS5248661A/ja
Priority to US05/749,282 priority patent/US4158060A/en
Priority to ES457872A priority patent/ES457872A1/es
Publication of FR2327771A2 publication Critical patent/FR2327771A2/fr
Priority to US05/807,172 priority patent/US4172143A/en
Priority to JP54145968A priority patent/JPS5846511B2/ja
Application granted granted Critical
Publication of FR2327771B2 publication Critical patent/FR2327771B2/fr
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/08—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon radicals, substituted by hetero atoms, attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D211/26—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by nitrogen atoms
FR7531334A 1974-12-18 1975-10-14 Nouveaux derives des methoxy-2 benzamides substitues, leurs sels, leur preparation et les medicaments qui en renferment Granted FR2327771A2 (fr)

Priority Applications (24)

Application Number Priority Date Filing Date Title
FR7531334A FR2327771A2 (fr) 1975-10-14 1975-10-14 Nouveaux derives des methoxy-2 benzamides substitues, leurs sels, leur preparation et les medicaments qui en renferment
CA241,723A CA1039731A (fr) 1974-12-18 1975-12-15 Synthese de derives de methoxy-2 benzamide
SE7514143A SE412908B (sv) 1974-12-18 1975-12-15 Forfarande for framstellning av terapeutiskt aktiva 2-metoxibensamider innehallande en pyrrolidin- eller en piperidinrest
DE2556457A DE2556457C3 (de) 1974-12-18 1975-12-15 N-(Pyrrolidin-2-yl-methyl)-2-methoxybenzamide, deren Salze, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel
IE2731/75A IE42210B1 (en) 1974-12-18 1975-12-15 2-methoxy-benzamide derivatives
LU74026A LU74026A1 (fr) 1974-12-18 1975-12-16
IL48678A IL48678A (en) 1974-12-18 1975-12-16 N-2-(pyrrolidinylmethyl)-2-methoxy-benzamide derivatives,their preparation and pharmaceutical compositions containing them
NLAANVRAGE7514620,A NL168219C (nl) 1974-12-18 1975-12-16 Werkwijze ter bereiding van een farmaceutisch preparaat met werking tegen nerveuze en psychosomatische aandoeningen en werkwijze ter bereiding van een heterocyclisch 2-methoxybenzamide-derivaat.
NO754284A NO143625C (no) 1974-12-18 1975-12-16 Analogifremgangsmaate for fremstilling av 2-metoksy-benzamider
GR49632A GR59205B (en) 1974-12-18 1975-12-17 New preparation method of methoxy-2-benzamides derivative
GB51635/75A GB1508880A (en) 1974-12-18 1975-12-17 2-methoxy-benzamide derivatives
ES75443563A ES443563A1 (es) 1974-12-18 1975-12-17 Un procedimiento de preparacion de derivados de metoxi-2-- benzamidas.
MX001641U MX3180E (es) 1974-12-18 1975-12-17 Procedimiento para preparar metoxi - 2 benzamidas
AU87646/75A AU497616B2 (en) 1974-12-18 1975-12-17 Pyrollidinyl benzamides
AT959075A AT353782B (de) 1974-12-18 1975-12-17 Verfahren zur herstellung von neuen 2-methoxy- benzamidderivaten, ihren razematen, optischen isomeren und saeureadditionssalzen
HU75SI1501A HU173391B (hu) 1974-12-18 1975-12-17 Sposob poluchenija proizvodnykh 2-metoksi-benzamida
DK574075A DK574075A (da) 1974-12-18 1975-12-17 Fremgangsmade til fremstilling af 2-methoxybenzamider
FI753586A FI753586A (fr) 1974-12-18 1975-12-18
CH1641375A CH612668A5 (fr) 1974-12-18 1975-12-18
JP2551576A JPS5248661A (en) 1975-10-14 1976-03-08 22methoxyybenzamide derivatives
US05/749,282 US4158060A (en) 1974-12-18 1976-12-10 2-Methoxy-benzamide derivatives
ES457872A ES457872A1 (es) 1974-12-18 1977-04-15 Un procedimiento de preparacion de derivados de metoxi 2- benzamidas.
US05/807,172 US4172143A (en) 1974-12-18 1977-06-16 2-Methoxy-benzamide derivatives
JP54145968A JPS5846511B2 (ja) 1975-10-14 1979-11-09 ２−メトキシベンズアミド誘導体

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR7531334A FR2327771A2 (fr) 1975-10-14 1975-10-14 Nouveaux derives des methoxy-2 benzamides substitues, leurs sels, leur preparation et les medicaments qui en renferment

Publications (2)

Publication Number Publication Date
FR2327771A2 true FR2327771A2 (fr) 1977-05-13
FR2327771B2 FR2327771B2 (fr) 1982-08-20

Family

ID=9161149

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7531334A Granted FR2327771A2 (fr) 1974-12-18 1975-10-14 Nouveaux derives des methoxy-2 benzamides substitues, leurs sels, leur preparation et les medicaments qui en renferment

Country Status (2)

Country Link
JP (1) JPS5846511B2 (fr)
FR (1) FR2327771A2 (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS57186185U (fr) * 1981-05-19 1982-11-26
WO1991017144A1 (fr) * 1990-05-02 1991-11-14 Yoshitomi Pharmaceutical Industries, Ltd. Compose amide, utilisation pharmaceutique de ce compose et nouvelles pyrrolidinemethyl-amines 1-substituee

Also Published As

Publication number Publication date
FR2327771B2 (fr) 1982-08-20
JPS5846511B2 (ja) 1983-10-17
JPS55113762A (en) 1980-09-02

Similar Documents

Publication Publication Date Title
SE8004002L (sv) Terapeutiskt anvendbara tetralinderivat
FI102175B1 (fi) Menetelmä terapeuttisesti käyttökelpoisten piperatsiinijohdannaisten valmistamiseksi
NO168643C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive dihydrobenzopyranderivater.
DE69510198D1 (de) Succinyl hydroxamsäure-, n-formyl-n-hydroxy-aminocarbonsäure- und succinsäureamid-derivate und ihre verwendung als metalloprotease-inhibitoren
NO159169C (no) Analogifremgansmaate for fremstilling av derivater av (okso-4-4h-(1)-benzopyran-8-yl)eddiksyre med antitumoral terapeutisk aktivitet.
DE3873578D1 (de) Verwendung von tetrahydrobenz(c,d)indol-6-carboxamiden zur herstellung von arzneimitteln zur behandlung von angstzustaenden.
FR2355796A1 (fr) Procede de preparation de fluorures d'acides perfluoro-alcoxy-propioniques
FR2327771A2 (fr) Nouveaux derives des methoxy-2 benzamides substitues, leurs sels, leur preparation et les medicaments qui en renferment
DE3462894D1 (de) 3-indolecarboxamide compounds
FR2331345A2 (fr) Nouveaux derives des methoxy-2 benzamides substitues, leurs sels, leur preparation et les medicaments qui en renferment
ES482889A1 (es) Procedimiento de preparacion de derivados de fluorenos y fluorantenos
HUT44933A (en) Process for preparing pharmaceuticals comprising carboxylic acidamides suitables for treating inflammatory and rheumatic diseases
GR852867B (fr)
PT69954B (pt) Process for preparing z-2-anylamino-3-monosubstituted propenoates
HUP9800964A2 (hu) O- és S-tartalmú 6 tagú benzo-kondenzált heterociklusos vegyületek, eljárás ezek előállítására, és ezeket tartalmazó gyógyászati készítmények
EP0230020A3 (en) 1,2,3,4,4a,9b-hexahydro-4a-aminoalkyldibenzofurans, a process for their preparation and their use as medicaments
ATE22557T1 (de) Bicyclo(4.2.0)oktatriene-1,3,5 derivate, verfahren zu deren herstellung und deren therapeutische anwendung.
ATE181503T1 (de) Verwendung von idazoxan und derivaten zur herstellung eines arzneimittels zur behandlung von parkinsonismus und seiner evolution
ZA917141B (en) 3-(1h-indazol-3-yl)-4-pyridinamines,a process and intermediates for their preparation and their use as medicaments
ATE24834T1 (de) Verwendung von beta-(1-adamantyl)-alpha, alphadimethylethylamin zur herstellung eines arzneimittels zur behandlung von otitis externa bei hunden.
ES8303401A1 (es) Un procedimiento para la preparacion de derivados del 4,9-dihidro-4,9-dioxo-1h-nafto (2,3-d)v-triazol.
JPS51115918A (en) Germicides for the porposes withowt medical treatment and method for p reparing them
FR2370473A1 (fr) Composition antipsoriatique contenant un derive de 3-sulfonoxy-azetidine en tant qu'agent actif
NO873571L (no) Fremgangsmaate for fremstilling av et terapeutisk virksomtpreparat.
NO910496L (no) Nye imidazolforbindelser og fremgangsmaate for fremstilling derav.